Tags

Type your tag names separated by a space and hit enter

Potent antihypertensive action of dietary flaxseed in hypertensive patients.
Hypertension. 2013 Dec; 62(6):1081-9.H

Abstract

Flaxseed contains ω-3 fatty acids, lignans, and fiber that together may provide benefits to patients with cardiovascular disease. Animal work identified that patients with peripheral artery disease may particularly benefit from dietary supplementation with flaxseed. Hypertension is commonly associated with peripheral artery disease. The purpose of the study was to examine the effects of daily ingestion of flaxseed on systolic (SBP) and diastolic blood pressure (DBP) in peripheral artery disease patients. In this prospective, double-blinded, placebo-controlled, randomized trial, patients (110 in total) ingested a variety of foods that contained 30 g of milled flaxseed or placebo each day over 6 months. Plasma levels of the ω-3 fatty acid α-linolenic acid and enterolignans increased 2- to 50-fold in the flaxseed-fed group but did not increase significantly in the placebo group. Patient body weights were not significantly different between the 2 groups at any time. SBP was ≈ 10 mm Hg lower, and DBP was ≈ 7 mm Hg lower in the flaxseed group compared with placebo after 6 months. Patients who entered the trial with a SBP ≥ 140 mm Hg at baseline obtained a significant reduction of 15 mm Hg in SBP and 7 mm Hg in DBP from flaxseed ingestion. The antihypertensive effect was achieved selectively in hypertensive patients. Circulating α-linolenic acid levels correlated with SBP and DBP, and lignan levels correlated with changes in DBP. In summary, flaxseed induced one of the most potent antihypertensive effects achieved by a dietary intervention.

Authors+Show Affiliations

St Boniface Hospital Research Centre, 351 Tache Ave, Winnipeg, Manitoba, Canada R2H 2A6. gpierce@sbrc.ca.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

24126178

Citation

Rodriguez-Leyva, Delfin, et al. "Potent Antihypertensive Action of Dietary Flaxseed in Hypertensive Patients." Hypertension (Dallas, Tex. : 1979), vol. 62, no. 6, 2013, pp. 1081-9.
Rodriguez-Leyva D, Weighell W, Edel AL, et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013;62(6):1081-9.
Rodriguez-Leyva, D., Weighell, W., Edel, A. L., LaVallee, R., Dibrov, E., Pinneker, R., Maddaford, T. G., Ramjiawan, B., Aliani, M., Guzman, R., & Pierce, G. N. (2013). Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension (Dallas, Tex. : 1979), 62(6), 1081-9. https://doi.org/10.1161/HYPERTENSIONAHA.113.02094
Rodriguez-Leyva D, et al. Potent Antihypertensive Action of Dietary Flaxseed in Hypertensive Patients. Hypertension. 2013;62(6):1081-9. PubMed PMID: 24126178.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Potent antihypertensive action of dietary flaxseed in hypertensive patients. AU - Rodriguez-Leyva,Delfin, AU - Weighell,Wendy, AU - Edel,Andrea L, AU - LaVallee,Renee, AU - Dibrov,Elena, AU - Pinneker,Reinhold, AU - Maddaford,Thane G, AU - Ramjiawan,Bram, AU - Aliani,Michel, AU - Guzman,Randolph, AU - Pierce,Grant N, Y1 - 2013/10/14/ PY - 2013/10/16/entrez PY - 2013/10/16/pubmed PY - 2014/1/1/medline KW - alpha linolenic acid KW - flax KW - hypertension KW - myocardial infarction KW - peripheral arterial disease KW - polyunsaturated fatty acid KW - stroke SP - 1081 EP - 9 JF - Hypertension (Dallas, Tex. : 1979) JO - Hypertension VL - 62 IS - 6 N2 - Flaxseed contains ω-3 fatty acids, lignans, and fiber that together may provide benefits to patients with cardiovascular disease. Animal work identified that patients with peripheral artery disease may particularly benefit from dietary supplementation with flaxseed. Hypertension is commonly associated with peripheral artery disease. The purpose of the study was to examine the effects of daily ingestion of flaxseed on systolic (SBP) and diastolic blood pressure (DBP) in peripheral artery disease patients. In this prospective, double-blinded, placebo-controlled, randomized trial, patients (110 in total) ingested a variety of foods that contained 30 g of milled flaxseed or placebo each day over 6 months. Plasma levels of the ω-3 fatty acid α-linolenic acid and enterolignans increased 2- to 50-fold in the flaxseed-fed group but did not increase significantly in the placebo group. Patient body weights were not significantly different between the 2 groups at any time. SBP was ≈ 10 mm Hg lower, and DBP was ≈ 7 mm Hg lower in the flaxseed group compared with placebo after 6 months. Patients who entered the trial with a SBP ≥ 140 mm Hg at baseline obtained a significant reduction of 15 mm Hg in SBP and 7 mm Hg in DBP from flaxseed ingestion. The antihypertensive effect was achieved selectively in hypertensive patients. Circulating α-linolenic acid levels correlated with SBP and DBP, and lignan levels correlated with changes in DBP. In summary, flaxseed induced one of the most potent antihypertensive effects achieved by a dietary intervention. SN - 1524-4563 UR - https://www.unboundmedicine.com/medline/citation/24126178/full_citation L2 - https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.113.02094?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -